Methypatch en es it fr

Methypatch Brand names, Methypatch Analogs

Methypatch Brand Names Mixture

  • No information avaliable

Methypatch Chemical_Formula


Methypatch RX_link

Methypatch fda sheet

Methypatch FDA

Methypatch msds (material safety sheet)

Methypatch MSDS

Methypatch Synthesis Reference

M. Hartmann, L. Panizzon, U.S. Pat. 2,507,631 (1950)

Methypatch Molecular Weight

233.306 g/mol

Methypatch Melting Point


Methypatch H2O Solubility


Methypatch State


Methypatch LogP


Methypatch Dosage Forms

Tablets; Tablets (sustained release)

Methypatch Indication

For use as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.

Methypatch Pharmacology

Methylphenidate is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine.

Methypatch Absorption

Readily absorbed in a biphasic manner. It reaches peak absorption at approximately two hours for the first phase and five hours for the second phase. Bioavailability is low (approximately 30%)

Methypatch side effects and Toxicity

Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes. LD50=190mg/kg (orally in mice)

Methypatch Patient Information

Methypatch Organisms Affected

Humans and other mammals